Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

498 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimating Lyapunov exponents in biomedical time series.
Porcher R, Thomas G. Porcher R, et al. Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Jul;64(1 Pt 1):010902. doi: 10.1103/PhysRevE.64.010902. Epub 2001 Jun 28. Phys Rev E Stat Nonlin Soft Matter Phys. 2001. PMID: 11461218
When to stop immunotherapy for advanced melanoma: the emulated target trials.
Amiot M, Mortier L, Dalle S, Dereure O, Dalac S, Dutriaux C, Leccia MT, Maubec E, Arnault JP, Brunet-Possenti F, De Quatrebarbes J, Granel-Brocard F, Gaudy-Marqueste C, Pages C, Stoebner PE, Saiag P, Lesimple T, Dupuy A, Legoupil D, Montaudié H, Oriano B, Lebbe C, Porcher R. Amiot M, et al. Among authors: porcher r. EClinicalMedicine. 2024 Dec 4;78:102960. doi: 10.1016/j.eclinm.2024.102960. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39717261 Free PMC article.
Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study.
Le Brun IC, Dalle S, Mortier L, Dereure O, Rat SD, Dutriaux C, Leccia MT, Legoupil D, Montaudié H, De Quatrebarbes J, Gaudy-Marqueste C, Maubec E, Saiag P, Pagès C, Possenti FB, Granel-Brocard F, Porcher R, Lefevre W, Lebbé C, Kempf E. Le Brun IC, et al. Among authors: porcher r. Cancer. 2024 Dec 8. doi: 10.1002/cncr.35679. Online ahead of print. Cancer. 2024. PMID: 39645590
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab versus nivolumab in a real-world setting.
Karine B, Mortier L, Dereure O, Dalac S, Montaudié H, Legoupil D, Dutriaux C, De Quatrebarbes J, Maubec E, Leccia MT, Granel-Brocard F, Brunet-Possenti F, Arnault JP, Gaudy-Marqueste C, Pages C, Saiag P, L'orphelin JM, Zehou O, Lesimple T, Allayous C, Porcher R, Oriano B, Dalle S, Lebbé C. Karine B, et al. Among authors: porcher r. Br J Dermatol. 2024 Nov 28:ljae470. doi: 10.1093/bjd/ljae470. Online ahead of print. Br J Dermatol. 2024. PMID: 39605282
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors.
Sorin B, Papo M, Sinico RA, Teixeira VS, Venhoff N, Urban ML, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Feder C, Kroegel C, Groh M, Marvisi C, Samson M, Barba T, Jayne D, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn JE, Bonnotte B, Durel CA, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Porcher R, Terrier B. Sorin B, et al. Among authors: porcher r. J Autoimmun. 2024 Dec;149:103338. doi: 10.1016/j.jaut.2024.103338. Epub 2024 Nov 16. J Autoimmun. 2024. PMID: 39549485
498 results